Berta Cistero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Berta Cistero has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Ceccato
Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Department of Medicine, Universitat Autonoma de Barcelona, Sabadell, Spain
1 shared publication Adriana Tomas
Emergency Department, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Sabadell, Spain
1 shared publication- Aida Fernandez
Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Department of Medicine, Universitat Autonoma de Barcelona, Sabadell, Spain
1 shared publication - Aina Areny-Balagueró
Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Department of Medicine, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain
1 shared publication - Antonio Artigas
Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Department of Medicine, Universitat Autonoma de Barcelona, Sabadell, Spain
1 shared publication - Antonio Casabella Pernas
Microbiology Section, Laboratory Medicine Department, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain
1 shared publication
Latest Publications
- Open Access
Longitudinal Measurements of Inflammatory Mediators in Patients at Risk of Sepsis in the Emergency Department
Sepsis is a complex condition with time⍰dependent evolution, and longitudinal biomarker dynamics may improve its characterisation. We hypothesised that biomarker kinetics are associated with sepsis, the intensity of organ dysfunction, and patient survival. This single⍰centre, prospective, observational study included adult patients presenting to the Emergency Department with suspected infection and a National Early Warning Score 2 (NEWS2) ≥3. Blood samples were collected at baseline, 4 and 24 hours. Linear mixed models assessed associations between biomarker trajectories, sepsis diagnosis, and organ dysfunction severity. Joint models evaluated the predictive value of biomarker kinetics during the first 24 hours for in⍰hospital mortality. Of 214 screened patients, 173 were analysed and 137(79%) developed sepsis. Linear mixed models showed significant time⍰dependent decreases in IL10(β −0.016, 95%CI −0.028 to −0.004), IL1RN(β −0.014, 95%CI −0.024 to −0.004), and IL6(β −0.012, 95%CI −0.024 to 0.00). Sepsis diagnosis was associated with higher IL1RN(β 0.378, 95%CI 0.153– 0.603) and TNFRSF1A(β 0.40, 95%CI 0.21–0.58); a significant interaction between sepsis and time was observed only for IL6. Increasing SOFA scores correlated with elevated IL10(β 0.048), IL1RN(β 0.044), CCL2(β 0.046), TNFRSF1A(β 0.050), and procalcitonin(PCT; β 2.63), all p<0.01. The SOFA–time interaction was significant only for IL6 (β −0.003, 95%CI −0.005 to −0.001). Joint survival models adjusted for age and maximum SOFA identified IL8 (HR 0.655, 95%CrI 0.582– 0.728), TNFRSF1A (HR 0.505, 95%CrI 0.419–0.682), and PCT (HR 1.004, 95%CrI 1.001– 1.008) as outcome predictors. In conclusion, sepsis and organ dysfunction severity are associated with distinct inflammatory biomarker levels and kinetics. IL6 showed a unique time⍰dependent relationship, while TNFRSF1A, IL8 and PCT dynamics were associated with survival.
Open AccessLongitudinal Measurements of Inflammatory Mediators in Patients at Risk of Sepsis in the Emergency Department
Sepsis is a complex condition with time⍰dependent evolution, and longitudinal biomarker dynamics may improve its characterisation. We hypothesised that biomarker kinetics are associated with sepsis, the intensity of organ dysfunction, and patient survival. This single⍰centre, prospective, observational study included adult patients presenting to the Emergency Department with suspected infection and a National Early Warning Score 2 (NEWS2) ≥3. Blood samples were collected at baseline, 4 and 24 hours. Linear mixed models assessed associations between biomarker trajectories, sepsis diagnosis, and organ dysfunction severity. Joint models evaluated the predictive value of biomarker kinetics during the first 24 hours for in⍰hospital mortality. Of 214 screened patients, 173 were analysed and 137(79%) developed sepsis. Linear mixed models showed significant time⍰dependent decreases in IL10(β −0.016, 95%CI −0.028 to −0.004), IL1RN(β −0.014, 95%CI −0.024 to −0.004), and IL6(β −0.012, 95%CI −0.024 to 0.00). Sepsis diagnosis was associated with higher IL1RN(β 0.378, 95%CI 0.153– 0.603) and TNFRSF1A(β 0.40, 95%CI 0.21–0.58); a significant interaction between sepsis and time was observed only for IL6. Increasing SOFA scores correlated with elevated IL10(β 0.048), IL1RN(β 0.044), CCL2(β 0.046), TNFRSF1A(β 0.050), and procalcitonin(PCT; β 2.63), all p<0.01. The SOFA–time interaction was significant only for IL6 (β −0.003, 95%CI −0.005 to −0.001). Joint survival models adjusted for age and maximum SOFA identified IL8 (HR 0.655, 95%CrI 0.582– 0.728), TNFRSF1A (HR 0.505, 95%CrI 0.419–0.682), and PCT (HR 1.004, 95%CrI 1.001– 1.008) as outcome predictors. In conclusion, sepsis and organ dysfunction severity are associated with distinct inflammatory biomarker levels and kinetics. IL6 showed a unique time⍰dependent relationship, while TNFRSF1A, IL8 and PCT dynamics were associated with survival.